Merck Drug Patents Asserted Against Gilead Valid, Jury Finds
A California federal jury said Tuesday that two patents held by Merck covering a key ingredient used in Gilead's blockbuster hepatitis C drugs were valid, setting the stage for a potential...To view the full article, register now.
Already a subscriber? Click here to view full article